|
WO1993017682A1
(en)
|
1992-03-04 |
1993-09-16 |
Abbott Laboratories |
Angiotensin ii receptor antagonists
|
|
GB9421816D0
(en)
|
1994-10-29 |
1994-12-14 |
Smithkline Beecham Plc |
Novel compounds
|
|
CN1175246A
(zh)
|
1994-12-22 |
1998-03-04 |
史密丝克莱恩比彻姆有限公司 |
用于治疗动脉粥样硬化的取代的氮杂环丁－2－酮
|
|
CH690264A5
(fr)
|
1995-06-30 |
2000-06-30 |
Symphar Sa |
Dérivés aminophosphonates substitués, leur procédé de préparation et leur utilisation pour la préparation de compositions pharmaceutiques.
|
|
JP2002515852A
(ja)
|
1995-07-01 |
2002-05-28 |
スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー |
アテローム性動脈硬化症の治療のためのアゼチジノン誘導体
|
|
EP0859834A2
(en)
|
1995-09-29 |
1998-08-26 |
Smithkline Beecham Plc |
A paf-acetylhydrolase and use in therapy
|
|
WO1997021675A1
(en)
|
1995-12-08 |
1997-06-19 |
Smithkline Beecham Plc |
Monocyclic beta-lactame derivatives for treatment of atherosclerosis
|
|
WO1997021676A1
(en)
|
1995-12-08 |
1997-06-19 |
Smithkline Beecham Plc |
Azetidinone compounds for the treatment of atherosclerosis
|
|
GB9608649D0
(en)
|
1996-04-26 |
1996-07-03 |
Smithkline Beecham Plc |
Novel compounds
|
|
NZ332476A
(en)
|
1996-04-26 |
2000-06-23 |
Smithkline Beecham Plc |
substituted 4-(carboxybenzylsulphinyl)-2-oxo-azetidine derivatives
|
|
GB9626615D0
(en)
|
1996-12-20 |
1997-02-05 |
Symphar Sa |
Novel compounds
|
|
GB9626536D0
(en)
|
1996-12-20 |
1997-02-05 |
Symphar Sa |
Novel compounds
|
|
GB9626616D0
(en)
|
1996-12-20 |
1997-02-05 |
Symphar Sa |
Novel compounds
|
|
WO1999024420A1
(en)
|
1997-11-06 |
1999-05-20 |
Smithkline Beecham Plc |
Pyrimidinone compounds and pharmaceutical compositions containing them
|
|
US6559155B1
(en)
|
1998-08-21 |
2003-05-06 |
Smithkline Beecham P.L.C. |
Pyrimidinone derivatives for the treatment of atherosclerosis
|
|
HUP0201122A3
(en)
|
1999-05-01 |
2003-11-28 |
Smithkline Beecham Plc |
Pyrimidinone compounds, process for their preparation and pharmaceutical compositions containing them
|
|
GB9910079D0
(en)
|
1999-05-01 |
1999-06-30 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB9910378D0
(en)
|
1999-05-05 |
1999-06-30 |
Smithkline Beecham Plc |
Novel compounds
|
|
JP3757703B2
(ja)
|
1999-09-22 |
2006-03-22 |
凸版印刷株式会社 |
再封可能な開口維持部材付パウチ
|
|
EP1686119B1
(en)
|
2000-02-16 |
2009-07-29 |
Smithkline Beecham Plc |
Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors
|
|
GB0024808D0
(en)
|
2000-10-10 |
2000-11-22 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB0024807D0
(en)
|
2000-10-10 |
2000-11-22 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB0119793D0
(en)
|
2001-08-14 |
2001-10-03 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB0119795D0
(en)
|
2001-08-14 |
2001-10-03 |
Smithkline Beecham Plc |
Novel process
|
|
GB0127141D0
(en)
|
2001-11-10 |
2002-01-02 |
Smithkline Beecham Plc |
Novel compounds
|
|
GB0127143D0
(en)
*
|
2001-11-10 |
2002-01-02 |
Smithkline Beecham |
Novel compounds
|
|
GB0127139D0
(en)
|
2001-11-10 |
2002-01-02 |
Smithkline Beecham |
Novel compounds
|
|
GB0127140D0
(en)
|
2001-11-10 |
2002-01-02 |
Smithkline Beecham |
Novel compounds
|
|
GB0208280D0
(en)
*
|
2002-04-10 |
2002-05-22 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0208279D0
(en)
*
|
2002-04-10 |
2002-05-22 |
Glaxo Group Ltd |
Novel compounds
|
|
EP1558606A4
(en)
|
2002-10-02 |
2008-05-07 |
Bristol Myers Squibb Co |
DIAMINOALKYL CONTAINING LACTAM, BETA AMINO ACIDS, ALPHA AMINO ACIDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS
|
|
MXPA05003607A
(es)
|
2002-10-04 |
2005-11-17 |
Prana Biotechnology Ltd |
Compuestos neurologicamente activos.
|
|
CA2530816A1
(en)
|
2003-07-02 |
2005-01-13 |
Bayer Healthcare Ag |
Amide-substituted 1,2,4-triazin-5(2h)-ones for the treatment of chronic inflammatory diseases
|
|
DE102004061009A1
(de)
|
2004-12-18 |
2006-06-22 |
Bayer Healthcare Ag |
Substituierte 1,2,4-Triazin-5(2H)-one
|
|
DE102004061008A1
(de)
|
2004-12-18 |
2006-06-22 |
Bayer Healthcare Ag |
3-Arylalkyl- und 3-Heteroarylalkyl-substituierte 1,2,4-Triazin-5(2H)-one
|
|
US20080090852A1
(en)
|
2006-10-13 |
2008-04-17 |
Colin Andrew Leach |
Bicyclic Heteroaromatic Compounds
|
|
US7705005B2
(en)
|
2006-10-13 |
2010-04-27 |
Glaxo Group Limited |
Bicyclic heteroaromatic compounds
|
|
US20080090851A1
(en)
|
2006-10-13 |
2008-04-17 |
Colin Andrew Leach |
Bicyclic Heteroaromatic Compounds
|
|
WO2008048867A2
(en)
*
|
2006-10-13 |
2008-04-24 |
Glaxo Group Limited |
Bicyclic heteroaromatic compounds
|
|
US8962633B2
(en)
|
2007-05-11 |
2015-02-24 |
Thomas Jefferson University |
Methods of treatment and prevention of metabolic bone diseases and disorders
|
|
US20080279846A1
(en)
*
|
2007-05-11 |
2008-11-13 |
Thomas Jefferson University |
Methods of treatment and prevention of neurodegenerative diseases and disorders
|
|
AU2008251467B2
(en)
|
2007-05-11 |
2014-07-31 |
The Trustees Of The University Of Pennsylvania |
Methods of treatment of skin ulcers
|
|
WO2009146034A2
(en)
|
2008-03-31 |
2009-12-03 |
Takeda Pharmaceutical Company Limited |
Mapk/erk kinase inhibitors and methods of use thereof
|
|
EP2521724B1
(en)
|
2009-12-11 |
2016-11-23 |
Nono Inc. |
Agents and methods for treating ischemic and other diseases
|
|
PE20140421A1
(es)
*
|
2010-12-06 |
2014-04-26 |
Glaxo Group Ltd |
COMPUESTOS DERIVADOS DE PIRIMIDINONA COMO INHIBIDORES DE Lp-PLA2
|
|
EP2651403B1
(en)
|
2010-12-17 |
2020-12-02 |
Glaxo Group Limited |
Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases
|
|
AR087309A1
(es)
*
|
2011-07-27 |
2014-03-12 |
Glaxo Group Ltd |
Compuesto heterociclico de anillos condensados sustituido, composicion farmaceutica que lo comprende y su uso para la fabricacion de un medicamento para el tratamiento de enfermedades neurogenerativas y aterosclerosis
|